Cancer · July 1, 2026
China Approves First CAR-T Therapy for Solid Tumors Globally
China's approval of the first solid tumor CAR-T therapy represents significant progress in cancer treatment....
Cancer · May 13, 2026
China Approves Clinical Trials for Dual-Action Cancer Drug SKB118
Kelun-Biotech's innovative PD-1 x VEGF bispecific antibody receives investigational approval for cancer treatment....